HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NO levels in diabetes mellitus: Effects of l-NAME and insulin on LCAT, Na(+)/K(+) ATPase activity and lipid profile.

AbstractOBJECTIVES:
Diabetes mellitus (DM) is a chronic disease and one of the most important health problems. Several factors may be responsible for the complications of diabetes mellitus including alterations in the activities of sodium-potassium adenosine triphosphatase (Na(+)/K(+) ATPase) and lecithin:cholesterol acyltransferase (LCAT) and also levels of nitric oxide (NO). We have investigated the effects of alterations in serum NO levels on activities of erythrocyte membran Na/K ATPase and serum LCAT enzymes.
MATERIALS AND METHODS:
The experiments were performed on male rats divided into four groups: group 1, control (standart diet); group 2, diabetic control (single dose of 65mg/kg of streptozotocin (STZ), i.p); group 3, STZ+insulin (8IU/kg/day s.c.); group 4 (STZ+l-NAME 5mg/kg/day orally).
RESULT:
Streptozotocin-induced diabetic rats, showed a significant increase in blood glucose and serum cholesterol (C) and triglyceride (TG). Compared to the control group with diabetic group plasma LCAT concentrations and erythrocyte membrane Na(+)/K(+) ATPase were found to be decreased. Activities of Na(+)/K(+) ATPase and serum NO level were decreased with the administration of l-NAME. We observed that insulin was ameliorated in all parameters.
CONCLUSIONS:
Serum NO levels is related to erythrocyte membrane Na(+)/K(+) ATPase activity. But serum NO levels did not affect the plasma LCAT activity and serum lipid profiles.
AuthorsNeslihan Tekin, Fahrettin Akyüz, Halide Edip Temel
JournalDiabetes & metabolic syndrome (Diabetes Metab Syndr) 2011 Oct-Dec Vol. 5 Issue 4 Pg. 191-5 ISSN: 1878-0334 [Electronic] Netherlands
PMID25572761 (Publication Type: Journal Article)
CopyrightCopyright © 2010 Diabetes India. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Blood Glucose
  • Enzyme Inhibitors
  • Hypoglycemic Agents
  • Insulin
  • Lipids
  • Nitric Oxide
  • Phosphatidylcholine-Sterol O-Acyltransferase
  • Sodium-Potassium-Exchanging ATPase
  • NG-Nitroarginine Methyl Ester
Topics
  • Animals
  • Blood Glucose (metabolism)
  • Cell Membrane (enzymology)
  • Diabetes Mellitus, Experimental (blood, drug therapy, pathology)
  • Enzyme Inhibitors (pharmacology)
  • Hypoglycemic Agents (pharmacology)
  • Insulin (pharmacology)
  • Lipids (blood)
  • Male
  • NG-Nitroarginine Methyl Ester (pharmacology)
  • Nitric Oxide (blood)
  • Phosphatidylcholine-Sterol O-Acyltransferase (blood)
  • Rats
  • Rats, Wistar
  • Sodium-Potassium-Exchanging ATPase (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: